] or all-trans retinoic acid (ATRA). Combination of low doses of ATRA or 1,25-dihydroxyvitamin D 3 that do not induce toxicity with another drug is a useful strategy for acute promyelocytic leukemia therapy. Our main aim was to investigate the effect of an acetone extract of D. kaki leaves (KV-1) on HL-60 cell differentiation in combination of ATRA or 1,25-dihydroxyvitamin D 3 . Treatment of HL-60 cells with zero to 100 μg/ml of KV-1 for 72 h induced a small increase in cell differentiation. Surprisingly, a synergistic induction of differentiation was observed when the HL-60 cells were treated with ATRA or 1,25-(OH) 2 D 3 and the extract. The inhibitors of protein kinase C (PKC) (· and ßI) and extracellular signalregulated kinase (ERK), but not of phosphoinositide 3-kinase (PI3-K) and c-Jun N-terminal kinase (JNK) inhibited the HL-60 differentiation induced by the extract in combination of ATRA or 1,25-(OH) 2 D 3 , suggesting that PKC and ERK were involved in the cell differentiation enhancement by the extract. The results indicate that the acetone extract of D. kaki leaves has the ability to enhance HL-60 cell differentiation and suggest that it may be useful in acute promyelocytic leukemia therapy.
Introduction
Diospyros kaki Thunb. (Ebenaceae), commonly called persimmon, is widely distributed throughout Korea, Japan, China and other northeast Asian countries. The crude plant extract of D. kaki is a very complex mixture containing compounds such as p-coumaric, gallic acid, catechin, flavonoids and tannin (1) . The phytochemicals present in D. kaki have been used for therapeutic purposes such as scavenging of hypercholesterolemia, antioxidant and free radicals; detoxification of snake venom and toxic substances produced by microorganisms; and inhibition of human lymphoid leukemia cells (2) . Vascorelaxant activity was also reported from D. kaki leaf extract (3) . Major constituents of D. kaki leaves responsible for pharmacological effect are tannins, flavonoids/coumarins and terpenoids (1) . Astragalin, a major constituent of flavonoids present in persimmon leaf extract, inhibited dermatitis development and IgE elevation in mice (4) . Four flavonoids compound isolated from persimmon leaves inhibited angiotensin-converting enzyme activity in dose-dependent fashion (5) . Similarly, five triterpenoids (6) and five flavonoids (7) compounds isolated from Diospyros kaki leaves have been reported to suppress stimulus-induced superoxide generation and tyrosyl phosphorylation in human neutrophils.
Most cancer cells are defective in their capacity to mature into non-replicating adult cells, thereby existing in a highly proliferating state and thus outgrowing their normal cellular counterparts. Leukaemia cells can be induced to undergo terminal differentiation by a variety of biochemical agents, indicating that the malignant state can be reversible. Leukemia may eventually prove treatable with agents that induce terminal differentiation, presumably with less morbidity than that associated with treatment with the cytodestructive agents (8). 1,25-dihydroxyvitamin D 3 [1, 2 D 3 ] and all-trans retinoic acid (ATRA) are well known to be able to induce terminal differentiation in leukemic cell lines, such as HL-60 and U-937, as well as in short-term cultured acute promyelocytic leukemia (APL) cells in human (9, 10) . However, an APL treatment by 1,25-(OH) 2 D 3 and ATRA at a high dose results in side effects including acquisition of drug resistance and hypercalcemia. Therefore, the current approach in solving this problem involves the introduction of a second chemical which enhances the differentiation-inducing effects of 1,25-(OH) 2 D 3 or ATRA at a lower, non-toxic concentration. HL-60 cells, extensively used as a model, differentiate into monocytic lineage when treated with 1,25-(OH) 2 D 3 and into granulocytic lineage when treated with ATRA (9,11), therefore this combination was selected for this study.
In the present study, we demonstrate that D. kaki leaf extract (KV-1) synergistically enhanced the differentiation potential of 1,25-(OH) 2 D 3 or ATRA, which may be useful in acute promyelocytic leukemia (APL) therapy.
Materials and methods
Materials. Diospyros kaki Thunb. leaves were collected from Jeonnam area, in October 2006. The plants were authenticated by the Department of Pharmacognosy, Chosun University. First, 2 litres of acetone/water (80:20, v/v) solution was added to 1 kg wet leaves and left at room temperature. After 2 years, residue was removed by centrifugation and the resulting acetone-aqueous solution was evaporated with a rotary evaporator at 40˚C. The resulting thick residue was washed three times with hexane and then dissolved in dichloromethane before evaporation. The final residue, KV-1 (540 mg), was stored at -20˚C until use. KV-1 was dissolved in dimethylsulfoxide (DMSO) to generate a 100 mg/ml stock solution. The solution was diluted at least 1,000-fold in the growth medium, such that the final DMSO concentration had no effect on the differentiation and proliferation behavior of the HL-60 cells. Determination of cell viability and differentiation. Cell viability was determined by the trypan blue exclusion assay, as previously described (12) . Viability was calculated as the percentage of live cells in the total cell population. Cell differentiation was assessed by the nitroblue tetrazolium (NBT) reduction assay as previously described (13) , which is based on the ability of phagocytic cells to produce superoxide upon stimulation with PMA. For the assay, cells were harvested by centrifugation at 3,000 x g and incubated with an equal volume of 1% NBT dissolved in phosphate-buffered saline (PBS) containing 200 ng/ml of freshly diluted PMA at 37˚C for 30 min in the dark. Cytospin slides were prepared and examined for a blue-black nitroblue diformazan deposit, indicative of a PMA-stimulated respiratory burst. At least 200 cells were assessed for each experiment.
Morphological studies. Single-cell suspensions were prepared and loaded into a cyto-funnel and spun at 1,050 x g in a cytospin centrifuge. The slides were fixed with methanol and dried. The slides were stained with a Giemsa staining solution for 20 min and rinsed in deionized water, air-dried and observed under a microscope with a camera. The stained cells were assessed for size, regularity of the cell margin and morphological characteristics of the nuclei.
Immunofluorescent staining and cytofluorometric measurements. The expression of cell surface molecules on cells was cytofluorometrically analyzed using a FACSCalibur flow cytometer (BD Bioscience, San Jose, CA). Briefly, a single-cell suspension was collected from each of the various cultures and washed twice with ice-cold PBS (pH 7.4). Afterwards, phycoerythrin (PE)-conjugated anti-human CD11b or fluorescein isothiocyanate (FITC)-conjugated anti-human CD14 mAbs (BD Bioscience) were added and incubated at 4˚C for 1 h. Next, the cells were washed with PBS and fixed in PBS containing 1% paraformaldehyde and then cytofluorometric analysis was performed. Background staining was determined by staining the cells with PE-or FITCconjugated isotype control mAbs. One parameter fluorescence histograms were generated by analyzing at least 1x10 4 cells.
Preparation of cell lysates and Western blot analysis.
Cells were lysed by incubating in lysis buffer (50 mM Tris buffer, pH 7.5 containing 100 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, 50 μg/ml leupeptin, 50 μg/ml aprotinin and 50 μg/ml phenylmethylsulphonyl fluoride) on ice for 30 min. Lysates were then centrifuged at 13,000 x g at 4˚C for 10 min. The proteins (10 μg) of the supernatants were separated using a 10% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) and transferred to the nitrocellulose membrane. The blots were probed with rabbit anti-human PKC isoforms, mouse anti-pJNK, rabbit anti-JNK, mouse anti-pERK and rabbit anti-ERK2 antibodies, washed and exposed to horseradish peroxidase-conjugated anti-mouse IgG2a or rabbit IgG antibodies. Immunoreactive bands were visualized by the enhanced chemiluminescence system (Amersham, Buckinghamshire, UK).
Statistical analysis. Student's t-test and one-way analysis of variance (ANOVA) followed by the Bonferroni method were used to determine the statistical significance of differences between the values of various experimental and control groups. A P-value of <0.05 was considered to be significant. (Fig. 1A) . Importantly, KV-1 synergistically potentiated 1,25-(OH) 2 D 3 -or ATRAinduced HL-60 cell differentiation. The effect of 5 nM 1,25-(OH) 2 D 3 or 50 nM ATRA in combination with 100 μg/ml KV-1 was considerably higher (>80%) than the effect observed in the individual treatment (<20%). For all treatment, cell viability was >97% throughout the incubation period, as demonstrated by the trypan blue exclusion assay (data not shown).
Results

Effect of KV-1 on 1,25-(OH)
Morphology of HL-60 cells was analyzed to further determine the cell differentiation enhanced by KV-1. Giemsastained undifferentiated control HL-60 cells (Fig. 1B) (upper left) were predominantly promyelocytes with round and regular cell margins and large nuclei, suggesting that the cells were highly active in DNA synthesis and were rapidly proliferating. HL-60 cells treated with 5 nM 1,25-(OH) 2 D 3 , 50 nM ATRA or 100 μg/ml KV-1 exhibited relatively small changes in cell morphology such as irregular cell margin. Combined treatment of HL-60 cells with 5 nM 1,25-(OH) 2 D 3 or 50 nM ATRA plus 100 μg/ml KV-1 resulted in a significantly decreased cell size, denser chromatin and increased cytoplasm to nuclear ratio, indicating the differentiation of HL-60 cells. Some cells showed a multilobed nucleus (Fig. 1B) , which is also a mark of cell differentiation.
Effects of KV-1 and 1,25-(OH) 2 D 3 or ATRA on differentiation pathways of HL-60 cells.
Cytofluorometric analysis was performed to determine the expression of specific surface antigens on HL-60 cells. HL-60 leukemia cells express a cell surface marker, CD11b, when the cells are differentiated into monocytes and granulocytes (14) . Treatment with KV-1 markedly increased the number of cells with high fluorescence intensity and also synergistically increased the number of the CD11b-positive cells when combined with either 5 nM 1,25-(OH) 2 D 3 or 50 nM ATRA, confirming that KV-1 potentiated 1,25-(OH) 2 D 3 -or ATRA-induced HL-60 cell differentiation ( Fig. 2A) .
To determine the differentiation pathway following treatment with KV-1 and ATRA or 1,25-(OH) 2 D 3 , the expression of CD14 antigen was cytofluorometrically analyzed on the treated HL-60 cells with KV-1 alone or in combination with either 1,25-(OH) 2 D 3 or ATRA. The CD14 antigen is exclusively expressed when cells are differentiated into monocytes (15) . HL-60 cells treated with a mixture of KV-1 and 1,25-(OH) 2 D 3 reacted very strongly with anti-CD14 mAb (Fig. 2B ). Cells treated with 1,25-(OH) 2 D 3 alone also reacted with the anti-CD14 mAb, but to a lesser extent than did the cells treated with a mixture of KV-1 and 1,25-(OH) 2 D 3 . These results indicate that KV-1 stimulated 1,25-(OH) 2 D 3 -induced HL-60 cell differentiation along the monocytic pathway. In contrast, HL-60 cells treated with a mixture of KV-1 and ATRA showed little staining with anti-CD14 mAb, although synergistic induction of cell differentiation was observed, as shown by NBT reduction assay. Alternatively, the HL-60 cell treated with a mixture of KV-1 and ATRA stained strongly with a monoclonal antibody against HL-60 cell differentiation marker CD11b ( Fig. 2A) , indicating that KV-1 stimulated ATRA induced HL-60 cell differentiation along the granulocytic pathway.
Involvement of PKC and ERK in the HL-60 cell differentiation induced by KV-1 in combination with 1,25-(OH) 2 D 3 or ATRA.
To determine if any relationship existed between the effect of KV-1 on 1,25-(OH) 2 D 3 -or ATRA-induced cell differentiation and activation of specific kinases involved in signaling pathways, the HL-60 cells were pretreated with each of specific inhibitors and incubated for 72 h in the presence of KV-1 alone or in combination with either 1,25-(OH) 2 D 3 or ATRA. Afterward, the degree of cell differentiation was assessed by an NBT reduction assay. The PI3-K inhibitors (wortmannin and LY 294002) and JNK inhibitor (SP 600125) did not inhibit HL-60 cell differentiation induced by KV-1 in combination with 1,25-(OH) 2 D 3 or ATRA (Fig. 3) . In contrast, the PKC inhibitors (GF 102903X, chelerythrine, H7 and PKC peptide inhibitor) (Fig. 4A ) and ERK inhibitor (PD 98059) (Fig. 5A ) notably suppressed the HL-60 cell differentiation treated with KV-1 in combination with 1,25-(OH) 2 D 3 or ATRA.
To further investigate the involvement of PKC in HL-60 cell differentiation enhanced by KV-1, the HL-60 cells were treated with 100 μg/ml KV-1 and the protein levels of PKC isoforms were determined by Western blot analysis using mAbs for each PKC isoform. In this study, we focused on the conventional PKC isoforms such as ·, ßI, ßII, as these PKC isoforms are known to be the most abundantly expressed in leukemia cells and the expression levels have been correlated closely with cell differentiation in HL-60 cells (16) . KV-1 increased protein levels of total PKC; in particular, KV-1 increased protein level of PKC· and PKC ßI, but not that of PKC ßII (Fig. 4B) . To further elucidate the involvement of ERK, the protein levels of ERK was determined by Western blot analysis. The levels of pERK increased by the treatment with KV-1 alone and KV-1 plus ATRA or 1,25-(OH) 2 D 3 (Fig. 5B) .
Discussion
In the present study, we demonstrated that KV-1 enhanced 1,25-(OH) 2 D 3 -and ATRA-induced differentiation in HL-60 leukemia cells, which are widely used as a model system for Previous studies have revealed that PKC activation is necessary for the differentiation of HL-60 cells (16, 22) and mitogen-activated protein kinases (MAPKs) are downstream elements in the PKC signaling pathway of HL-60 cells (23) . The c-Jun N-terminal kinase (JNK) signaling module is also known to participate in myeloid cell differentiation (24, 25) . Phosphatidylinositol 3-kinase (PI3-K) activity plays an essential role in differentiation of HL-60 cells (26) . Here, a combination of KV-1 with 1,25-(OH) 2 D 3 or ATRA contributed to the activation of the PKC and ERK, but not that of PI3-K or JNK-mediated pathways, as demonstrated by Western blot analyses and kinase inhibitor studies, although protein levels of the conventional PKC isoforms · and ßI increased at different extent (Figs. 3-5 ). Taken together, the results suggest that KV-1 potentiates ATRA-and 1,25-(OH) 2 D 3 -induced HL-60 cell differentiation through distinct pathways through PKC(·, ßI)/ERK without involvement of PI3-K and JNK (Fig. 5C ). Recently, we have shown that a methanol extract of Panax ginseng synergistically induced differentiation potential of ATRA and 1,25-(OH) 2 D 3 with the involvement of PKC/ERK, but not that of PI3-K (27) .
Phytochemicals present in D. kaki have several pharmacological effects including potential inhibitory effects on human lymphoid leukemia cells (1) (2) (3) (4) . Major constituents of D. kaki leaves responsible for pharmacological effect are flavonoids and terpenoids (1, (4) (5) (6) (7) . Therefore, although we could not pinpoint the exact active compound present in acetone extract of KV-1, flavonoid and/or terpenoid compound might be responsible for ATRA and 1,25-(OH) 2 D 3 -induced HL-60 differentiation. Epidemiological studies suggest that there is a low risk of many kinds of cancer to the people who eat large amounts of fruits and vegetables (28) . Although the underlying reason is largely unclear, various dietary chemicals such as curcuminoids, and carotenoids may possibly prevent human cancer in part by synergizing endogenously produced differentiation stimulators such as retinoic acids and 1,25-(OH) 2 D 3 .
In summary, an acetone extract of D. kaki leaves markedly increased the HL-60 cell differentiation in combination of a low dose of 1,25-(OH) 2 
